CRISPR Enzyme Shreds Cancer DNA in Early Tests
Science
⚠ Single-source○●○
1h ago

CRISPR Enzyme Shreds Cancer DNA in Early Tests

AI-synthesized · Bias removed · Facts only

Researchers have discovered a CRISPR enzyme capable of destroying cancer cells by directly shredding their DNA. Initial testing indicates the protein can be targeted to cells with tumor-causing mutations.

A new CRISPR enzyme is showing promise in early tests as a potential cancer treatment, according to research published in *Nature* on July 24, 2026. The enzyme functions by physically destroying the DNA within cancerous cells.

The key innovation lies in the method of attack. Unlike some gene-editing approaches that aim to correct mutations, this protein directly dismantles the genetic material. Early tests suggest it can be directed towards cells harboring mutations known to drive tumor growth. The research, detailed with DOI 10.1038/d41586-026-02268-z, represents a novel approach to cancer therapy.

The article notes that the findings are preliminary, but highlight a potentially significant advancement in utilizing CRISPR technology for direct cancer cell destruction.

Was this useful?

How we processed this story

  • ✓ Neutralized — Loaded language, emotional intensifiers, and editorial framing were stripped from the original coverage. Direct quotes are preserved verbatim. The change log is available on request.
  • ● Coverage — Three dots show whether left, center, and right outlets in our pool covered this story. Filled means yes, hollow means no. One-sided coverage is shown honestly — we don't hide it, and we don't penalize it.
  • ⚠ Wire — Flagged when "multiple" outlets are reprinting the same wire-service copy. Several reprints of one AP story are not three independent perspectives.

We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.

Read the original coverage

● Center Nature Read original ↗

💬 Comments

📜 Comment Policy